Community voices, strategies to improve understanding, and access to prostate cancer genomic testing.
Ewan K Cobran, Jocelyn Turner, Sarah E James and 9 others
PMID 42143434WHAT IT FOUND
Prostate cancer survivors, caregivers, and community members said they often confuse tumor-based genomic testing with ancestry or inherited risk.
They asked for plain-language visuals, family-inclusive conversations, trusted messengers, and help with cost and coverage.
Key findings
01Participants had minimal familiarity with tissue-based genomic testing, often confused it with ancestry or hereditary testing, and asked for plain-language visual distinctions.
02Fear, stigma, and masculine norms were described as major barriers to prostate cancer screening and genomic testing.
03Participants described prostate cancer decisions as family-centered, identified cost, insurance, and navigation as major barriers, said education alone would not fix access, and favored trusted community messengers and culturally relevant communication.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study reports perceptions and suggested strategies, not measured effects on testing uptake, comprehension, or patient outcomes. Focus groups were conducted in English, so non-English-speaking individuals and some Spanish-speaking populations may be missing. Community Advisory Board members were purposively recruited, not randomly selected, so the findings may not represent all prostate cancer patients or communities. Participants may have been more engaged in health initiatives than the wider community. The paper notes that many genomic tests were developed and validated in cohorts with limited representation of Black and other minoritized populations, so access barriers may not be the only inequity. The article reports eight focus groups in one place and nine in another, so the exact number of discussions is unclear. Themes are reported as distribution across focus groups, not as how many participants held them, so it does not show how common each view was.
Declared interests
The supplied text says all other authors declared no potential conflicts of interest. It does not describe funding or a sponsor.
The easy way to misread this
Do not read these community recommendations as evidence that plain-language genomic education, caregiver inclusion, or trusted messengers improve testing uptake or patient outcomes. This was a qualitative study of perceptions and suggested strategies, not a test of effects.